Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    DiaMedica Therapeutics In...

    NASDAQ: DMAC · Real-Time Price · USD
    3.82
    -0.13 (-3.29%)
    At close: Jun 26, 2025, 3:59 PM
    3.81
    -0.26%
    After-hours: Jun 26, 2025, 04:04 PM EDT

    DiaMedica Therapeutics Statistics

    Share Statistics

    DiaMedica Therapeutics has 42.88M shares outstanding. The number of shares has increased by 12.89% in one year.

    Shares Outstanding

    n/a
    		 42.88M

    Shares Change (YoY)

    n/a
    		 12.89%

    Shares Change (QoQ)

    n/a
    		 0.22%

    Owned by Institutions (%)

    n/a
    		 15.74%

    Shares Floating

    n/a
    		 24.15M

    Failed to Deliver (FTD) Shares

    n/a
    		 7,664

    FTD / Avg. Volume

    n/a
    		 7.04%

    Short Selling Information

    The latest short interest is 1.1M, so 2.56% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 1.1M

    Short % of Shares Out

    n/a
    		 2.56%

    Short % of Float

    n/a
    		 4.07%

    Short Ratio (days to cover)

    n/a
    		 10.77

    Valuation Ratios

    The PE ratio is -8.98 and the forward PE ratio is -4.9. DiaMedica Therapeutics's PEG ratio is 0.

    PE Ratio

    n/a
    		 -8.98

    Forward PE

    n/a
    		 -4.9

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 2.1

    PB Ratio

    n/a
    		 5.39

    P/FCF Ratio

    n/a
    		 -9.93

    PEG Ratio

    n/a
    		 0
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for DiaMedica Therapeutics.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 8.28, with a Debt / Equity ratio of 0.01.

    Current Ratio

    n/a
    		 8.28

    Quick Ratio

    n/a
    		 8.28

    Debt / Equity

    n/a
    		 0.01

    Debt / EBITDA

    n/a
    		 -0.01

    Debt / FCF

    n/a
    		 -0.02

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-905,333.33

    Employee Count

    n/a
    		 27

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 30K

    Effective Tax Rate

    n/a
    		 -0.12%

    Stock Price Statistics

    The stock price has increased by 25.25% in the last 52 weeks. The beta is 1.2, so DiaMedica Therapeutics's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.2

    52-Week Price Change

    n/a
    		 25.25%

    50-Day Moving Average

    n/a
    		 3.96

    200-Day Moving Average

    n/a
    		 4.73

    Relative Strength Index (RSI)

    n/a
    		 46.89

    Average Volume (20 Days)

    n/a
    		 108,879

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -26.68M

    Net Income

    n/a
    		 -24.44M

    EBITDA

    n/a
    		 -24.38M

    EBIT

    n/a
    		 -24.41M

    Earnings Per Share (EPS)

    n/a
    		 -0.6
    Full Income Statement

    Balance Sheet

    The company has 3.02M in cash and 340K in debt, giving a net cash position of 2.69M.

    Cash & Cash Equivalents

    n/a
    		 3.02M

    Total Debt

    n/a
    		 340K

    Net Cash

    n/a
    		 2.69M

    Retained Earnings

    n/a
    		 -140M

    Total Assets

    n/a
    		 38.83M

    Working Capital

    n/a
    		 32.76M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -22.08M and capital expenditures -25K, giving a free cash flow of -22.1M.

    Operating Cash Flow

    n/a
    		 -22.08M

    Capital Expenditures

    n/a
    		 -25K

    Free Cash Flow

    n/a
    		 -22.1M

    FCF Per Share

    n/a
    		 -0.55
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    DMAC does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for DMAC is $8, which is 109.4% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $8

    Price Target Difference

    n/a
    		 109.4%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 2
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Nov 15, 2018. It was a backward split with a ratio of 1:20.

    Last Split Date

    n/a
    		 Nov 15, 2018

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:20

    Scores

    Altman Z-Score

    n/a
    		 15.17

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist